Cytokine storm and the prospects for immunotherapy with COVID-19 | Cleveland Clinic Journal of Medicine
Targeting the “Cytokine Storm” for Therapeutic Benefit | Clinical and Vaccine Immunology
Importance of selectively targeting the mode | EurekAlert!
Cytokine Referencing Guide · Cytokine citation (updated Feb 21 2023) · Citationsy
Cytokine Storm Therapy Market Size In 2022 By Fastest Growing Companies with top Players – Moderna , Gilead Sciences, Pfizer, Johnson & Johnson - Digital Journal
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes - The Lancet Respiratory Medicine
International Journal of Cytokine | IJCY | Open Access Pub
Cytokine | Cytokines in immune pathogenesis and therapy | ScienceDirect.com by Elsevier
Cytokine & Growth Factor Reviews | Journal | ScienceDirect.com by Elsevier
Cytokine Storm | NEJM
Microorganisms | Free Full-Text | Epidemiological and Cytokine Profile of Patients with Pulmonary and Extrapulmonary Tuberculosis in a Population of the Brazilian Amazon
PDF) Cytokine, cytokine storm and their role in fatalities of COVID-19
The signal pathways and treatment of cytokine storm in COVID-19 | Signal Transduction and Targeted Therapy
Cytokine - Wikipedia
Journal of Interferon & Cytokine Research | Mary Ann Liebert, Inc., publishers
Transcriptional Profiles of Cytokine/Chemokine Factors of Immune Cell-Homing to the Parasitic Lesions: A Comprehensive One-Year Course Study in the Liver of E. multilocularis-Infected Mice | PLOS ONE
Journal of Cytokine Biology- Open Access Journals
Journal of Interferon & Cytokine Research | Mary Ann Liebert, Inc., publishers
Cytokine storm syndrome in coronavirus disease 2019: A narrative review - Gao - 2021 - Journal of Internal Medicine - Wiley Online Library
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Interleukin-28 and 29 (IL-28 and IL-29): New Cytokines with Anti-Viral Activities - D. Kempuraj, J. Donelan, S. Frydas, T. Iezzi, F. Conti, W. Boucher, N. G. Papadopoulou, B. Madhappan, L. Letourneau, J.
Journal of Interferon and Cytokine Research impact... | Exaly
